Induction of apoptosis in uninfected lymphocytes by HIV-1 Tat protein.

Apoptosis: a review of programmed cell death. Toxicol Pathol (2007) 17.92

Regulation of apoptosis by viral gene products. J Virol (1997) 3.67

The landscape of human proteins interacting with viruses and other pathogens. PLoS Pathog (2008) 3.11

Human immunodeficiency virus type 1 Vpr induces apoptosis following cell cycle arrest. J Virol (1997) 2.82

Viral control of mitochondrial apoptosis. PLoS Pathog (2008) 2.21

Altering the tropism of lentiviral vectors through pseudotyping. Curr Gene Ther (2005) 2.21

Upregulation of Fas ligand expression by human immunodeficiency virus in human macrophages mediates apoptosis of uninfected T lymphocytes. J Virol (1996) 2.07

Resistance to apoptosis conferred by Cdk inhibitors during myocyte differentiation. Science (1996) 2.03

Contribution of nonneutralizing vaccine-elicited antibody activities to improved protective efficacy in rhesus macaques immunized with Tat/Env compared with multigenic vaccines. J Immunol (2009) 1.93

Interleukin-1 beta converting enzyme-like protease involvement in Fas-induced and activation-induced peripheral blood T cell apoptosis in HIV infection. TNF-related apoptosis-inducing ligand can mediate activation-induced T cell death in HIV infection. J Exp Med (1997) 1.89

Bcl-2 down-regulates the activity of transcription factor NF-kappaB induced upon apoptosis. J Cell Biol (1996) 1.71

Interferon alpha and Tat involvement in the immunosuppression of uninfected T cells and C-C chemokine decline in AIDS. Proc Natl Acad Sci U S A (1998) 1.68

HIV-1 directly kills CD4+ T cells by a Fas-independent mechanism. J Exp Med (1998) 1.66

An inducible human immunodeficiency virus type 1 (HIV-1) vector which effectively suppresses HIV-1 replication. J Virol (1999) 1.61

Human parvovirus B19 nonstructural (NS1) protein induces apoptosis in erythroid lineage cells. J Virol (1998) 1.61

Apoptosis control in syncytia induced by the HIV type 1-envelope glycoprotein complex: role of mitochondria and caspases. J Exp Med (2000) 1.59

Reawakening the cellular death program in neoplasia through the therapeutic blockade of IAP function. J Clin Invest (2005) 1.55

Human immunodeficiency virus type 1 vectors efficiently transduce human hematopoietic stem cells. J Virol (1998) 1.54

Tat protein induces human immunodeficiency virus type 1 (HIV-1) coreceptors and promotes infection with both macrophage-tropic and T-lymphotropic HIV-1 strains. J Virol (1998) 1.52

HIV-1 Tat targets microtubules to induce apoptosis, a process promoted by the pro-apoptotic Bcl-2 relative Bim. EMBO J (2002) 1.50

HIV-1 kills renal tubular epithelial cells in vitro by triggering an apoptotic pathway involving caspase activation and Fas upregulation. J Clin Invest (1998) 1.49

Cell cycle and apoptosis. Neoplasia (2001) 1.47

Varicella-zoster virus-infected human sensory neurons are resistant to apoptosis, yet human foreskin fibroblasts are susceptible: evidence for a cell-type-specific apoptotic response. J Virol (2003) 1.46

Th17 and regulatory T cells: implications for AIDS pathogenesis. Curr Opin HIV AIDS (2010) 1.45

Transcriptional profiles of latent human immunodeficiency virus in infected individuals: effects of Tat on the host and reservoir. J Virol (2003) 1.40

Apoptosis induced by HIV-1 infection of the central nervous system. J Clin Invest (1996) 1.40

HIV-1 Tat enters T cells using coated pits before translocating from acidified endosomes and eliciting biological responses. Mol Biol Cell (2004) 1.38

A replication-competent adenovirus-human immunodeficiency virus (Ad-HIV) tat and Ad-HIV env priming/Tat and envelope protein boosting regimen elicits enhanced protective efficacy against simian/human immunodeficiency virus SHIV89.6P challenge in rhesus macaques. J Virol (2007) 1.36

Importance of membrane fusion mediated by human immunodeficiency virus envelope glycoproteins for lysis of primary CD4-positive T cells. J Virol (2000) 1.35

Human immunodeficiency virus type 1 Tat induces apoptosis and increases sensitivity to apoptotic signals by up-regulating FLICE/caspase-8. J Virol (1999) 1.35

Tat as one key to HIV-induced immune pathogenesis and Tat (correction of Pat) toxoid as an important component of a vaccine. Proc Natl Acad Sci U S A (1999) 1.32

Induction of the chemokines interleukin-8 and IP-10 by human immunodeficiency virus type 1 tat in astrocytes. J Virol (2000) 1.32

Distinct mechanisms of CD4+ and CD8+ T-cell activation and bystander apoptosis induced by human immunodeficiency virus type 1 virions. J Virol (2005) 1.31

The HIV-1 vpr protein acts as a negative regulator of apoptosis in a human lymphoblastoid T cell line: possible implications for the pathogenesis of AIDS. J Exp Med (1998) 1.30

Increased loss of CCR5+ CD45RA- CD4+ T cells in CD8+ lymphocyte-depleted Simian immunodeficiency virus-infected rhesus monkeys. J Virol (2008) 1.30

Membrane-fusing capacity of the human immunodeficiency virus envelope proteins determines the efficiency of CD+ T-cell depletion in macaques infected by a simian-human immunodeficiency virus. J Virol (2001) 1.29

Distinct mechanisms trigger apoptosis in human immunodeficiency virus type 1-infected and in uninfected bystander T lymphocytes. J Virol (1998) 1.29

Poliovirus induces apoptosis in the mouse central nervous system. J Virol (1999) 1.27

Extracellular human immunodeficiency virus type 1 Tat protein is associated with an increase in both NF-kappa B binding and protein kinase C activity in primary human astrocytes. J Virol (1996) 1.27

Tat protein of human immunodeficiency virus type 1 induces interleukin-10 in human peripheral blood monocytes: implication of protein kinase C-dependent pathway. J Virol (2000) 1.27

Levels of major selenoproteins in T cells decrease during HIV infection and low molecular mass selenium compounds increase. Proc Natl Acad Sci U S A (1999) 1.25

Monocytes treated with human immunodeficiency virus Tat kill uninfected CD4(+) cells by a tumor necrosis factor-related apoptosis-induced ligand-mediated mechanism. J Virol (2003) 1.25

Activation of an interleukin 1 converting enzyme-dependent apoptosis pathway by granzyme B. Proc Natl Acad Sci U S A (1996) 1.20

Tat protein induces self-perpetuating permissivity for productive HIV-1 infection. Proc Natl Acad Sci U S A (1997) 1.20

Potent inhibition of tumor survival in vivo by beta-lapachone plus taxol: combining drugs imposes different artificial checkpoints. Proc Natl Acad Sci U S A (1999) 1.20

A link between cell cycle and cell death: Bax and Bcl-2 modulate Cdk2 activation during thymocyte apoptosis. EMBO J (1998) 1.19

Rapid induction of apoptosis by cell-to-cell transmission of human immunodeficiency virus type 1. J Virol (1995) 1.15

What does the structure-function relationship of the HIV-1 Tat protein teach us about developing an AIDS vaccine? Retrovirology (2009) 1.15

Priming of human CD4+ antigen-specific T cells to undergo apoptosis by HIV-infected monocytes. A two-step mechanism involving the gp120 molecule. J Clin Invest (1997) 1.14

HIV-1 infection impairs cell cycle progression of CD4(+) T cells without affecting early activation responses. J Clin Invest (2001) 1.13

Selective killing of cancer cells by beta -lapachone: direct checkpoint activation as a strategy against cancer. Proc Natl Acad Sci U S A (2003) 1.13

Angiogenic effects of extracellular human immunodeficiency virus type 1 Tat protein and its role in the pathogenesis of AIDS-associated Kaposi's sarcoma. Clin Microbiol Rev (2002) 1.12

Death of CD4(+) T-cell lines caused by human immunodeficiency virus type 1 does not depend on caspases or apoptosis. J Virol (2002) 1.12

Cytopathic killing of peripheral blood CD4(+) T lymphocytes by human immunodeficiency virus type 1 appears necrotic rather than apoptotic and does not require env. J Virol (2002) 1.12

Preferential cytolysis of peripheral memory CD4+ T cells by in vitro X4-tropic human immunodeficiency virus type 1 infection before the completion of reverse transcription. J Virol (2008) 1.12

Both wild-type and strongly attenuated bovine leukemia viruses protect peripheral blood mononuclear cells from apoptosis. J Virol (1997) 1.11

Immunoregulatory effects of morphine on human lymphocytes. Clin Diagn Lab Immunol (1997) 1.10

Activation of transcription factor NF-kappaB by the Tat protein of human immunodeficiency virus type 1. J Virol (1996) 1.10

The transmembrane domains of Sindbis virus envelope glycoproteins induce cell death. J Virol (1998) 1.09

Pronounced acute immunosuppression in vivo mediated by HIV Tat challenge. Proc Natl Acad Sci U S A (1999) 1.08

Human immunodeficiency virus-1 tat induces hyperproliferation and dysregulation of renal glomerular epithelial cells. Am J Pathol (2002) 1.08

Extracellular matrix remodeling and the regulation of epithelial-stromal interactions during differentiation and involution. Kidney Int Suppl (1996) 1.07

CD4+ T cell depletion in human immunodeficiency virus (HIV) infection: role of apoptosis. Viruses (2011) 1.07

Prevention of disease induced by a partially heterologous AIDS virus in rhesus monkeys by using an adjuvanted multicomponent protein vaccine. J Virol (2003) 1.06

HIV-1 Tat protein enhances microtubule polymerization. Retrovirology (2005) 1.06

Comparative study of Tat vaccine regimens in Mauritian cynomolgus and Indian rhesus macaques: influence of Mauritian MHC haplotypes on susceptibility/resistance to SHIV(89.6P) infection. Vaccine (2008) 1.05

Alternatively spliced products CC3 and TC3 have opposing effects on apoptosis. Mol Cell Biol (2000) 1.05

Recombinant human immunodeficiency virus type 1 genomes with tat unconstrained by overlapping reading frames reveal residues in Tat important for replication in tissue culture. J Virol (1996) 1.04

Induction of MHC class I expression on immature thymocytes in HIV-1-infected SCID-hu Thy/Liv mice: evidence of indirect mechanisms. J Immunol (1999) 1.03

Outcome of simian-human immunodeficiency virus strain 89.6p challenge following vaccination of rhesus macaques with human immunodeficiency virus Tat protein. J Virol (2002) 1.03

Cardiomyocytes undergo apoptosis in human immunodeficiency virus cardiomyopathy through mitochondrion- and death receptor-controlled pathways. Proc Natl Acad Sci U S A (2002) 1.02

Increased inducible apoptosis in CD4+ T lymphocytes during polymicrobial sepsis is mediated by Fas ligand and not endotoxin. Immunology (1999) 1.02

Apoptosis of bystander T cells induced by human immunodeficiency virus type 1 with increased envelope/receptor affinity and coreceptor binding site exposure. J Virol (2004) 1.02

Severe acute respiratory syndrome coronavirus 3a protein is released in membranous structures from 3a protein-expressing cells and infected cells. J Virol (2006) 1.00

Tat-induced FOXO3a is a key mediator of apoptosis in HIV-1-infected human CD4+ T lymphocytes. J Immunol (2008) 1.00

Association of Tat with promoters of PTEN and PP2A subunits is key to transcriptional activation of apoptotic pathways in HIV-infected CD4+ T cells. PLoS Pathog (2010) 0.99

Loss of CD4+ T cells in human immunodeficiency virus type 1-infected chimpanzees is associated with increased lymphocyte apoptosis. J Virol (1998) 0.98

Release of mitochondrial cytochrome C in both apoptosis and necrosis induced by beta-lapachone in human carcinoma cells. Mol Med (1999) 0.98

Cytolysis by CCR5-using human immunodeficiency virus type 1 envelope glycoproteins is dependent on membrane fusion and can be inhibited by high levels of CD4 expression. J Virol (2003) 0.96

Role of the Fas/Fas ligand apoptotic pathway in human immunodeficiency virus type 1 disease. J Virol (1998) 0.96

Anti-retroviral therapy reverses HIV-associated abnormalities in lymphocyte apoptosis. Clin Exp Immunol (1998) 0.95

Modifications in host cell cytoskeleton structure and function mediated by intracellular HIV-1 Tat protein are greatly dependent on the second coding exon. Nucleic Acids Res (2010) 0.94

Functional domains of Tat required for efficient human immunodeficiency virus type 1 reverse transcription. J Virol (1999) 0.94

Polyreactive antibodies plus complement enhance the phagocytosis of cells made apoptotic by UV-light or HIV. Sci Rep (2013) 0.93

Vitamin E inhibits CD95 ligand expression and protects T cells from activation-induced cell death. J Clin Invest (2002) 0.93

Resistance of chimpanzee T cells to human immunodeficiency virus type 1 Tat-enhanced oxidative stress and apoptosis. J Virol (1996) 0.93

A major human immunodeficiency virus type 1-initiated killing pathway distinct from apoptosis. J Virol (1997) 0.93

HIV-1 Tat protein binds to TLR4-MD2 and signals to induce TNF-α and IL-10. Retrovirology (2013) 0.93

Chondrocyte Apoptosis in the Pathogenesis of Osteoarthritis. Int J Mol Sci (2015) 0.91

bc1-2 expression facilitates human immunodeficiency virus type-1 mediated cytopathic effects during acute spreading infections. J Virol (1996) 0.91

HIV-1 Tat, apoptosis and the mitochondria: a tubulin link? Retrovirology (2005) 0.91

Reservoir cells no longer detectable after a heterologous SHIV challenge with the synthetic HIV-1 Tat Oyi vaccine. Retrovirology (2006) 0.90

Virion-associated Vpr of human immunodeficiency virus type 1 triggers activation of apoptotic events and enhances fas-induced apoptosis in human T cells. J Virol (2009) 0.90

Modulation of microtubule assembly by the HIV-1 Tat protein is strongly dependent on zinc binding to Tat. Retrovirology (2008) 0.90

A portrait of the Bcl-2 protein family: life, death, and the whole picture. J Clin Immunol (1999) 0.90

HIV-1 pathogenesis and therapeutic intervention in the SCID-hu Thy/Liv mouse: a model for primary HIV-1 infection in the human thymus. Rev Med Virol (1997) 0.89

Inhibition of human immunodeficiency virus envelope glycoprotein- mediated single cell lysis by low-molecular-weight antagonists of viral entry. J Virol (2006) 0.89

Necrosis and apoptosis in the gastrointestinal tract. Gut (1995) 0.88

HIV-1 Tat protein induces the production of IDO in human monocyte derived-dendritic cells through a direct mechanism: effect on T cells proliferation. PLoS One (2013) 0.88

HIV-1 Tat inhibits NGF-induced Egr-1 transcriptional activity and consequent p35 expression in neural cells. J Cell Physiol (2008) 0.88

Expression monitoring by hybridization to high-density oligonucleotide arrays. Nat Biotechnol (1996) 72.84

Differential display of eukaryotic messenger RNA by means of the polymerase chain reaction. Science (1992) 24.32

Activation of the IkappaB kinase complex by TRAF6 requires a dimeric ubiquitin-conjugating enzyme complex and a unique polyubiquitin chain. Cell (2000) 10.90

Penicillin-binding proteins and cell shape in E. coli. Nature (1975) 10.20

A restriction point for control of normal animal cell proliferation. Proc Natl Acad Sci U S A (1974) 8.74

Positive and negative regulation of transcription in vitro: enhancer-binding protein AP-2 is inhibited by SV40 T antigen. Cell (1987) 7.51

Cell-cycle control of c-myc but not c-ras expression is lost following chemical transformation. Cell (1984) 6.53

A controlled trial of fluconazole to prevent fungal infections in patients undergoing bone marrow transplantation. N Engl J Med (1992) 6.06

Distribution and cloning of eukaryotic mRNAs by means of differential display: refinements and optimization. Nucleic Acids Res (1993) 5.82

Animal cell cycle. Annu Rev Biochem (1978) 4.80

DNA synthesis inhibition and the induction of protein X in Escherichia coli. J Mol Biol (1976) 4.65

Membrane transport proteins. Proteins that appear to be parts of membrane transport systems are being isolated and characterized. Science (1968) 4.23

Cytidine triphosphate synthetase of Escherichia coli B. I. Purification and kinetics. J Biol Chem (1967) 4.01

Transport changes rapidly initiated by serum addition to "contact inhibited" 3T3 cells. Proc Natl Acad Sci U S A (1969) 3.98

Lowry determination of protein in the presence of Triton X-100. Anal Biochem (1975) 3.94

Putative contributors to the secular increase in obesity: exploring the roads less traveled. Int J Obes (Lond) (2006) 3.90

Changes of membrane proteins and their relation to deoxyribonucleic acid synthesis and cell division of Escherichia coli. J Biol Chem (1970) 3.76

Multiple pathways of putrescine biosynthesis in Escherichia coli. J Biol Chem (1966) 3.74

Inhibition of an early event in the cell division cycle of Escherichia coli by FL1060, an amidinopenicillanic acid. J Bacteriol (1975) 3.49

Comparative toxicity of trivalent and pentavalent inorganic and methylated arsenicals in rat and human cells. Arch Toxicol (2000) 3.46

Model for regulation of Escherichia coli DNA repair functions. Proc Natl Acad Sci U S A (1975) 3.32

Downregulation of major histocompatibility complex class I molecules by Kaposi's sarcoma-associated herpesvirus K3 and K5 proteins. J Virol (2000) 3.30

Synchronization of tumor and normal cells from G1 to multiple cell cycles by lovastatin. Cancer Res (1991) 3.24

Potent neutralization of botulinum neurotoxin by recombinant oligoclonal antibody. Proc Natl Acad Sci U S A (2002) 3.16

Differential display and cloning of messenger RNAs from human breast cancer versus mammary epithelial cells. Cancer Res (1992) 3.12

Multienzyme complex for metabolic channeling in mammalian DNA replication. Proc Natl Acad Sci U S A (1980) 3.12

Transport of amino acids by confluent and nonconfluent 3T3 and polyoma virus-transformed 3T3 cells growing on glass cover slips. J Biol Chem (1969) 3.05

A binding site for sulfate and its relation to sulfate transport into Salmonella typhimurium. J Biol Chem (1966) 3.04

Results of cardiopulmonary resuscitation. Failure to predict survival in two community hospitals. Arch Intern Med (1993) 3.02

Inhibition of extracellular signal-regulated kinase enhances Ischemia/Reoxygenation-induced apoptosis in cultured cardiac myocytes and exaggerates reperfusion injury in isolated perfused heart. Circ Res (2000) 2.93

Quality of life (QoL) analyses from OPTIMAL (CTONG-0802), a phase III, randomised, open-label study of first-line erlotinib versus chemotherapy in patients with advanced EGFR mutation-positive non-small-cell lung cancer (NSCLC). Ann Oncol (2013) 2.92

Caffeine-induced uncoupling of mitosis from the completion of DNA replication in mammalian cells. Science (1986) 2.89

Redundant cyclin overexpression and gene amplification in breast cancer cells. Proc Natl Acad Sci U S A (1993) 2.85

Centriole ciliation is related to quiescence and DNA synthesis in 3T3 cells. Cell (1979) 2.84

Evidence that specific T lymphocytes may participate in the elimination of chronic myelogenous leukemia. Nat Med (2000) 2.78

Species identification of coagulase-negative staphylococcal isolates from blood cultures. J Clin Microbiol (1982) 2.71

The anatomic basis of parathyroid surgery. Ann Surg (1976) 2.70

Purification and properties of a sulfate-binding protein from Salmonella typhimurium. J Biol Chem (1966) 2.69

A Nedd8 conjugation pathway is essential for proteolytic targeting of p27Kip1 by ubiquitination. Proc Natl Acad Sci U S A (2000) 2.69

Heat shock proteins are methylated in avian and mammalian cells. Proc Natl Acad Sci U S A (1981) 2.68

Conditional mutations involving septum formation in Escherichia coli. J Bacteriol (1967) 2.64

Identifying individuals with physcian diagnosed COPD in health administrative databases. COPD (2009) 2.61

Investigation, treatment and monitoring of late-onset hypogonadism in males. Aging Male (2005) 2.60

Pestivirus translation initiation occurs by internal ribosome entry. Virology (1995) 2.56

Evidence for a relationship between deoxyribonucleic acid metabolism and septum formation in Escherichia coli. J Bacteriol (1968) 2.54

Inhibition of natural killer cell-mediated cytotoxicity by Kaposi's sarcoma-associated herpesvirus K5 protein. Immunity (2000) 2.53

Crystallographic structures of the ligand-binding domains of the androgen receptor and its T877A mutant complexed with the natural agonist dihydrotestosterone. Proc Natl Acad Sci U S A (2001) 2.44

Ketamine anesthesia during the first week of life can cause long-lasting cognitive deficits in rhesus monkeys. Neurotoxicol Teratol (2011) 2.41

Thymidine and thymine incorporation into deoxyribonucleic acid: inhibition and repression by uridine of thymidine phosphorylase of Escherichia coli. J Bacteriol (1967) 2.41

The role of inherited TPMT and COMT genetic variation in cisplatin-induced ototoxicity in children with cancer. Clin Pharmacol Ther (2013) 2.40

p300 and p300/cAMP-response element-binding protein-associated factor acetylate the androgen receptor at sites governing hormone-dependent transactivation. J Biol Chem (2000) 2.31

Synthesis of labile, serum-dependent protein in early G1 controls animal cell growth. Proc Natl Acad Sci U S A (1979) 2.28

A highly divergent picornavirus in a marine mammal. J Virol (2007) 2.23

The surgical management of paraduodenal hernia. Ann Surg (1968) 2.20

Sequence of enzyme synthesis and gene replication during the cell cycle of Bacillus subtilis. Proc Natl Acad Sci U S A (1965) 2.18

Valaciclovir compared with acyclovir for improved therapy for herpes zoster in immunocompetent adults. Antimicrob Agents Chemother (1995) 2.16

Bovine interstitial retinol-binding protein (IRBP)--isolation and sequence analysis of cDNA clones, characterization and in vitro translation of mRNA. Vision Res (1986) 2.16

Bgl II RFLP recognized by a human IRBP cDNA localized to chromosome 10. Nucleic Acids Res (1987) 2.15

Location of sulfate-binding protein in Salmonella typhimurium. J Bacteriol (1968) 2.11

Importance of ICOS-B7RP-1 costimulation in acute and chronic allograft rejection. Nat Immunol (2001) 2.10

V(D)J recombination in Ku86-deficient mice: distinct effects on coding, signal, and hybrid joint formation. Immunity (1997) 2.10

Insuring Latinos against the costs of illness. JAMA (1993) 2.09

Oldest playable musical instruments found at Jiahu early Neolithic site in China. Nature (1999) 2.08

Regulation of sulfate transport in Salmonella typhimurium. J Bacteriol (1966) 2.06

A permeable animal cell preparation for studying macromolecular synthesis. DNA synthesis and the role of deoxyribonucleotides in S phase initiation. Biochemistry (1978) 2.05

Thermodynamics and structure of a DNA tetraplex: a spectroscopic and calorimetric study of the tetramolecular complexes of d(TG3T) and d(TG3T2G3T). Proc Natl Acad Sci U S A (1992) 2.03

Overexpression of the hyaluronan receptor RHAMM is transforming and is also required for H-ras transformation. Cell (1995) 1.99

Long-term pharmacokinetics of transdermal testosterone gel in hypogonadal men. J Clin Endocrinol Metab (2000) 1.99

Changes in the synthesis of actin and other cell proteins after stimulation of serum-arrested cells. Proc Natl Acad Sci U S A (1979) 1.95

Functional differences between memory and naive CD8 T cells. Proc Natl Acad Sci U S A (1999) 1.94

Epidermal growth factor-induced nuclear factor kappa B activation: A major pathway of cell-cycle progression in estrogen-receptor negative breast cancer cells. Proc Natl Acad Sci U S A (2000) 1.94

Data from men in greater Seattle area reveals no downward trend in semen quality: further evidence that deterioration of semen quality is not geographically uniform. Fertil Steril (1996) 1.93

Inhibition of p38 mitogen-activated protein kinase decreases cardiomyocyte apoptosis and improves cardiac function after myocardial ischemia and reperfusion. Circulation (1999) 1.93

Restriction point control of cell growth by a labile protein: evidence for increased stability in transformed cells. Proc Natl Acad Sci U S A (1982) 1.93

Odontogenic tumors. A demographic study of 759 cases in a Chinese population. Oral Surg Oral Med Oral Pathol Oral Radiol Endod (1998) 1.93

Evidence for a sulfate-binding site external to the cell membrane of Salmonella typhimurium. Biochim Biophys Acta (1965) 1.93

Cell-free activity of a sulfate binding site involved in active transport. Proc Natl Acad Sci U S A (1966) 1.92

Genetics of sulfate transport by Salmonella typhimurium. J Bacteriol (1971) 1.92

Deoxyribonucleic acid synthesis during the division cycle of Escherichia coli: a comparison of strains B-r, K-12, 15, and 15T- under conditions of slow growth. J Bacteriol (1974) 1.90

A biosynthetic ornithine decarboxylase in Escherichia coli. Biochem Biophys Res Commun (1965) 1.87

Control of thymidine kinase mRNA during the cell cycle. Mol Cell Biol (1987) 1.86

Hepatic cytochrome P450s metabolize aristolochic acid and reduce its kidney toxicity. Kidney Int (2008) 1.86

Abrogation of the G2 cell cycle checkpoint associated with overexpression of HSIX1: a possible mechanism of breast carcinogenesis. Proc Natl Acad Sci U S A (1998) 1.86

Mechanism by which caffeine potentiates lethality of nitrogen mustard. Proc Natl Acad Sci U S A (1982) 1.86

Differential display using one-base anchored oligo-dT primers. Nucleic Acids Res (1994) 1.85

Neuronal somatic ATP release triggers neuron-satellite glial cell communication in dorsal root ganglia. Proc Natl Acad Sci U S A (2007) 1.85

Pumilio is essential for function but not for distribution of the Drosophila abdominal determinant Nanos. Genes Dev (1992) 1.85

The 289-amino acid E1A protein of adenovirus binds zinc in a region that is important for trans-activation. Proc Natl Acad Sci U S A (1988) 1.84

Variations in KCNQ1 are associated with type 2 diabetes and beta cell function in a Chinese population. Diabetologia (2009) 1.83

Cyclin E, a potential prognostic marker for breast cancer. Cancer Res (1994) 1.82

Somatic mutations of the MEN1 tumor suppressor gene in sporadic gastrinomas and insulinomas. Cancer Res (1997) 1.82

Role of direct interaction in BRCA1 inhibition of estrogen receptor activity. Oncogene (2001) 1.82

Androgen receptor: an overview. Crit Rev Eukaryot Gene Expr (1995) 1.81

PSA-NCAM is required for activity-induced synaptic plasticity. Neuron (1996) 1.81

Drg-1 as a differentiation-related, putative metastatic suppressor gene in human colon cancer. Cancer Res (2000) 1.80

Pentoxifylline (Trental) decreases the replication of the human immunodeficiency virus type 1 in human peripheral blood mononuclear cells and in cultured T cells. Blood (1991) 1.80

Rapid incorporation of label from ribonucleoside disphosphates into DNA by a cell-free high molecular weight fraction from animal cell nuclei. Cell (1983) 1.76

Recent advances in differential display. Curr Opin Immunol (1995) 1.75

Cell division in Escherichia coli: evidence for regulation of septation by effector molecules. J Mol Biol (1972) 1.74

F-box protein Skp2: a novel transcriptional target of E2F. Oncogene (2006) 1.74